Work

Prospective pilot trial with combination of propranolol with chemotherapy in patients with epithelial ovarian cancer and evaluation on circulating immune cell gene expression

Year: 2019

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2019.07.004

Authors: Lois M. Ramondetta, Wei Hu, Premal H. Thaker, Diana L. Urbauer, Gary B. Chisholm, Shannon N. Westin, Yunjie Sun, Pedro T. Ramirez, Nicole Fleming, Sunil K. Sahai, Alpa M. Nick, Jesusa M.G. Arevalo, Thomas Dizon, Robert L. Coleman, Steve W. Cole, Anil K. Sood

Institutions: The University of Texas MD Anderson Cancer Center, Washington University in St. Louis, University of Tennessee Health Science Center, University of California, Los Angeles

Language: English

Topic: Cancer, Stress, Anesthesia, and Immune Response

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Cancer Prevention and Research Institute of Texas, AbbVie, Frank McGraw Memorial Chair in Cancer Research, Gateway Foundation, National Institutes of Health, National Cancer Institute, Janssen Pharmaceuticals

Awards: G111615301, U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer, G3383841576, G7349318094, G9000034222

OpenAlex ID: W2962858117

FWCI: 3.86

Cites: 40

Cited by: 49

Related to: 10